Charlene Liao is the founder of Immune-Onc Therapeutics. Immune-Onc Therapeutics has raised $110M in total funding. Latest round: Series B.
Charlene Liao is the co-founder of Immune-Onc Therapeutics, a biopharmaceutical company based in Palo Alto that focuses on developing immuno-oncology therapeutics for cancer treatment. She has led the company since its founding in 2016, overseeing fundraising that has surpassed $110 million and advancing lead programs.
Full founder directory · Investor directory · Company funding database · Fundraising library